微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Profound Medical (NASDAQ:PROF) +29%
STAAR Surgical (NASDAQ:STAA) +20%
AdaptHealth (NASDAQ:AHCO) +15%
Flora Growth (NASDAQ:FLGC) +12%
Invacare (NYSE:IVC) +14%
L...查看全文
Nevro(NVRO)2022-10-07 04:33
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-018321 Size: 4 KB 网页链接查看全文
Nevro(NVRO)2022-10-05 05:57
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-018217 Size: 4 KB 网页链接查看全文
Nevro(NVRO)2022-10-05 05:57
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-018222 Size: 4 KB 网页链接查看全文
Nevro(NVRO)2022-10-05 05:51
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-018214 Size: 4 KB 网页链接查看全文
Nevro(NVRO)2022-10-05 05:57
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-018224 Size: 8 KB 网页链接查看全文
夹头博士DrChuck2023-07-29 21:35
回复@陈达美股投资: 相当专业,$Nevro(NVRO)$ 不幸的落入了苟延残喘的境地,不过21年大放水时也超过了霸道总裁的情节。估值确实是科学和艺术的结合,严谨分析财报和模型的科学家总被疯狂的市场艺术家调戏~//@陈达美股投资:回复@Hello朱:我知乎上那篇巨长的手把手教你DCF,有网友反映被大学corpora...查看全文
蹊之美股生物医药2021-08-06 22:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Profound Medical (NASDAQ:PROF) +29%
STAAR Surgical (NASDAQ:STAA) +20%
AdaptHealth (NASDAQ:AHCO) +15%
Flora Growth (NASDAQ:FLGC) +12%
Invacare (NYSE:IVC) +14%
L...查看全文
郁闷的鞋套-2021-07-20 12:42
$Nevro(NVRO)$ 2021年7月19日,Nevro公司宣布,其专有的10 kHZ脊髓刺激(SCS)“Senza”系统,已获得美国FDA批准,用于治疗疼痛性糖尿病神经病变(PDN)引起的慢性疼痛。新闻稿指出,这是FDA批准的首款以PDN为适应症的脊髓刺激系统。该公司将根据本次批准,推出的名为“HFX”的PDN治疗相关产品。HF...查看全文
智通财经APP获悉,鉴于多数大型医疗科技公司已公开表示有意在该领域进行收购,摩根大通分析师Robbie Marcus列出了潜在的收购目标,包括:英特格拉生命科学(IART.US)、Nevro (NVRO.US)、纽瓦索器材(NUVA.US)、Silk Road Medical (SILK.US... 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000207 Size: 4 KB 网页链接
$Nevro(NVRO)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-044100 Act: 34 Size: 6 MB 网页链接
$Nevro(NVRO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-044108 Act: 34 Size: 1 MB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000204 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000200 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000201 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000202 Size: 8 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000203 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000159 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000144 Size: 6 KB 网页链接